WEEKLY POSITION MONITOR UPDATE
On Monday’s Health Care Webcast, we will cover:
- Race for a Liquid Biopsy Alternative | On the last position monitor update, we discussed Illumina’s ($ILMN) recently announced $8 billion acquisition of Grail, an early cancer detection startup. Following last week’s announcement, Exact Sciences ($EXAS) unveiled impressive, albeit not entirely comparable, data from their own liquid biopsy collaboration. As said by one of our experts earlier this year, “Someone will figure it out, but it’s anyone’s guess who that will be.”
- GDRX IPO Check, Now What? | After setting original pricing guidance of $24-$28, GoodRx began trading Wednesday at $46/share, up over 50% from its final IPO price of $33. Now that the shares have been priced and have begun trading, what is next for the stock focused on solving the age-old dilemma of pharmacy pricing? On Monday, we will preview the initial work we have done on the potential opportunity going forward.
|
Health Care Webcast | Race for a Liquid Biopsy Alternative & GoodRx IPO Please join us on Monday, September 28, 2020 @ 2 PM ET - Add to Outlook Calendar FREE: CLICK HERE for event details (including video and materials links). |
RECAP OF Recent EVENTS
Genetic Testing Trends | Claims Index For EXAS+GHDX, NVTA, NTRA, ADPT, GH, NEO
CLICK HERE to access the associated note.
Field Notes | GDRX, TDOC, CVS, ANTM | GDRX Could Evolve to One-Stop Shop, But Payors Remain for Now
CLICK HERE to access the associated note.
Health Care Webcast | AMWL Recap, Telehealth Apps & Survey, Claims Data, #Nofluseason
CLICK HERE for event details (includes video link and materials link).
All data available upon request. Please reach out to with any inquiries.
